Lansoprazol Ranbaxy (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This irreversible inhibition stops the final step of acid production, leading to a sustained reduction in gastric acidity and an increase in stomach pH.

The appropriate dose and duration are determined by the prescribing clinician based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made together with a qualified health‑care professional.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the proton pump inhibitor class, which generally provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs like omeprazole, it has a similar efficacy profile but may differ slightly in metabolism and drug‑interaction potential.

Store the tablets at room temperature, preferably below 25 °C, in the original blister pack or container. Keep them away from moisture, direct sunlight and heat sources to maintain product stability.

The tablets are taken orally, usually with a glass of water. For most indications they are recommended to be taken before a meal, often in the morning, but patients should follow the specific timing advised by their prescriber.

Serious but rare adverse events include Clostridioides difficile‑associated colitis, severe allergic reactions such as Stevens‑Johnson syndrome, and electrolyte disturbances like hypomagnesemia. Any signs of severe rash, persistent diarrhea, muscle cramps or irregular heartbeat should prompt immediate medical evaluation.

Patients with known hypersensitivity to lansoprazole or any other proton pump inhibitor should avoid the product. Caution is also advised for individuals with severe liver disease, those taking certain interacting medications, and patients for whom acid suppression is contraindicated as determined by their health‑care provider.